HFR Fribourg - Hôpital cantonal
Fribourg 1708
1 studies enrolling now · 5 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Heart Failure With Left Bundle Branch Block, Psoriatic Arthritis, Rheumatoid Arthritis
Studies at this site
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
- A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
- AdaptResponse Clinical Trial — Completed
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
- PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed